186 related articles for article (PubMed ID: 23086420)
21. The myotubularin family: novel phosphoinositide regulators.
Nandurkar HH; Huysmans R
IUBMB Life; 2002 Jan; 53(1):37-43. PubMed ID: 12018406
[TBL] [Abstract][Full Text] [Related]
22. The myotubularin family of lipid phosphatases.
Clague MJ; Lorenzo O
Traffic; 2005 Dec; 6(12):1063-9. PubMed ID: 16262718
[TBL] [Abstract][Full Text] [Related]
23. Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.
Raess MA; Cowling BS; Bertazzi DL; Kretz C; Rinaldi B; Xuereb JM; Kessler P; Romero NB; Payrastre B; Friant S; Laporte J
Hum Mol Genet; 2017 Oct; 26(19):3736-3748. PubMed ID: 28934386
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of X-linked myotubular myopathy by detection of myotubularin.
Laporte J; Kress W; Mandel JL
Ann Neurol; 2001 Jul; 50(1):42-6. PubMed ID: 11456308
[TBL] [Abstract][Full Text] [Related]
25. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.
Berger P; Bonneick S; Willi S; Wymann M; Suter U
Hum Mol Genet; 2002 Jun; 11(13):1569-79. PubMed ID: 12045210
[TBL] [Abstract][Full Text] [Related]
26. The PTEN and Myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease.
Davies EM; Sheffield DA; Tibarewal P; Fedele CG; Mitchell CA; Leslie NR
Subcell Biochem; 2012; 58():281-336. PubMed ID: 22403079
[TBL] [Abstract][Full Text] [Related]
27. Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology.
Hnia K; Vaccari I; Bolino A; Laporte J
Trends Mol Med; 2012 Jun; 18(6):317-27. PubMed ID: 22578719
[TBL] [Abstract][Full Text] [Related]
28. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
[TBL] [Abstract][Full Text] [Related]
29. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking.
Cao C; Backer JM; Laporte J; Bedrick EJ; Wandinger-Ness A
Mol Biol Cell; 2008 Aug; 19(8):3334-46. PubMed ID: 18524850
[TBL] [Abstract][Full Text] [Related]
30. Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2.
Berger P; Berger I; Schaffitzel C; Tersar K; Volkmer B; Suter U
Hum Mol Genet; 2006 Feb; 15(4):569-79. PubMed ID: 16399794
[TBL] [Abstract][Full Text] [Related]
31. Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2.
Tersar K; Boentert M; Berger P; Bonneick S; Wessig C; Toyka KV; Young P; Suter U
Hum Mol Genet; 2007 Dec; 16(24):2991-3001. PubMed ID: 17855448
[TBL] [Abstract][Full Text] [Related]
32. The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression.
Ng AA; Logan AM; Schmidt EJ; Robinson FL
Hum Mol Genet; 2013 Apr; 22(8):1493-506. PubMed ID: 23297362
[TBL] [Abstract][Full Text] [Related]
33. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
Dowling JJ; Vreede AP; Low SE; Gibbs EM; Kuwada JY; Bonnemann CG; Feldman EL
PLoS Genet; 2009 Feb; 5(2):e1000372. PubMed ID: 19197364
[TBL] [Abstract][Full Text] [Related]
34. Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo.
Amoasii L; Hnia K; Chicanne G; Brech A; Cowling BS; Müller MM; Schwab Y; Koebel P; Ferry A; Payrastre B; Laporte J
J Cell Sci; 2013 Apr; 126(Pt 8):1806-19. PubMed ID: 23444364
[TBL] [Abstract][Full Text] [Related]
35. Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.
Taylor GS; Maehama T; Dixon JE
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8910-5. PubMed ID: 10900271
[TBL] [Abstract][Full Text] [Related]
36. Multiple disease-linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerization.
Goryunov D; Nightingale A; Bornfleth L; Leung C; Liem RK
J Neurochem; 2008 Mar; 104(6):1536-52. PubMed ID: 17973976
[TBL] [Abstract][Full Text] [Related]
37. Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans.
Dang H; Li Z; Skolnik EY; Fares H
Mol Biol Cell; 2004 Jan; 15(1):189-96. PubMed ID: 14565969
[TBL] [Abstract][Full Text] [Related]
38. An In Vitro Model of Charcot-Marie-Tooth Disease Type 4B2 Provides Insight Into the Roles of MTMR13 and MTMR2 in Schwann Cell Myelination.
Robinson DC; Mammel AE; Logan AM; Larson AA; Schmidt EJ; Condon AF; Robinson FL
ASN Neuro; 2018; 10():1759091418803282. PubMed ID: 30419760
[TBL] [Abstract][Full Text] [Related]
39. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
[TBL] [Abstract][Full Text] [Related]
40. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module.
Berger P; Schaffitzel C; Berger I; Ban N; Suter U
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12177-82. PubMed ID: 14530412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]